Evidence map›Paper›PMID 30472687›Full record

ArticleIET systems biology2018

Dynamic optimal experimental design yields marginal improvement over steady-state results for computational maximisation of regulatory T-cell induction in ex vivo culture.

Andrew Sinkoe, Arul Jayaraman, Juergen Hahn

Abstract read
In one paragraph

Article in IET systems biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew SinkoeCenter for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, New York, USA.
Arul JayaramanMcFerrin Department of Chemical Engineering, Texas A&M University, College Station, Texas, USA.
Juergen HahnDepartment of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, 110 8th Street, Troy, New York, USA. hahnj@rpi.edu.

Funding

Modeling and Analysis of the Role of Microbiota Metabolites in T-Cell DifferentiationR01AI110642 · NIAID · TEXAS ENGINEERING EXPERIMENT STATION · PI ALANIZ, ROBERT CHRISTOPHER, HAHN, JUERGEN · 2015 to 2019
$2.0M
NIAID NIH HHS R01 AI110642
6 · The paper itself

Abstract

The isolation of T cells, followed by differentiation into Regulatory T cells (Tregs), and re-transplantation into the body has been proposed as a therapeutic option for inflammatory bowel disease. A key requirement for making this a viable therapeutic option is the generation of a large population of Tregs. However, cytokines in the local microenvironment can impact the yield of Tregs during differentiation. As such, experimental design is an essential part of evaluating the importance of different cytokine concentrations for Treg differentiation. However, currently only single, constant concentrations of the cytokines have been investigated. This work addresses this point by performing experimental design in silico which seeks to maximize the predicted induction of Tregs relative to Th17 cells, by selecting an optimal input function for the concentrations of TGF-β, IL-2, IL-6, and IL-23. While this approach sounds promising, the results show that only marginal improvements in the concentration of Tregs can be achieved for dynamic cytokine profiles as compared to optimal constant concentrations. Since constant concentrations are easier to implement in experiments, it is recommended for this particular system to keep the concentrations constant where IL-6 should be kept low and high concentrations of TGF-β, IL-2, and IL-23 should be used.

Indexed as

Computer SimulationCell DifferentiationCells, CulturedCytokinesDose-Response Relationship, DrugSignal TransductionTh17 CellsT-Lymphocytes, RegulatoryCytokines

Identifiers

PMID30472687
PMCPMC8687199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.